65 related articles for article (PubMed ID: 1948253)
1. Endogenous tumor necrosis factor-alpha in patients with nasopharyngeal carcinoma.
Yadav M
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):123-6. PubMed ID: 1948253
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
[TBL] [Abstract][Full Text] [Related]
3. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis].
Li D; Li G; Wang B
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763
[TBL] [Abstract][Full Text] [Related]
4. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha levels in serum and cerebrospinal fluid of patients with AIDS.
Franciotta DM; Melzi d'Eril GL; Bono G; Brustia R; Ruberto G; Pagani I
Funct Neurol; 1992; 7(1):35-8. PubMed ID: 1582576
[TBL] [Abstract][Full Text] [Related]
8. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
[TBL] [Abstract][Full Text] [Related]
9. Estimation of tumor necrosis factor-alpha in the diagnosis, the prognosis and the treatment follow-up of oral squamous cell carcinoma.
Kurokawa H; Yamashita M; Yamashita Y; Murata T; Miura K; Kajiyama M
Fukuoka Igaku Zasshi; 1998 Nov; 89(11):312-20. PubMed ID: 9884462
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
[TBL] [Abstract][Full Text] [Related]
12. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma].
Peng J; Ding T; Zheng LM; Shao JY
Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898
[TBL] [Abstract][Full Text] [Related]
13. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of elevated serum sICAM-1 in patients with nasopharyngeal carcinoma].
Wang L; Shu M; Wei Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):469-71. PubMed ID: 12768764
[TBL] [Abstract][Full Text] [Related]
16. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
18. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
Su TR; Chang KL; Lee CH; Chen CH; Yang YH; Shieh TY
Oral Oncol; 2004 Sep; 40(8):804-10. PubMed ID: 15288835
[TBL] [Abstract][Full Text] [Related]
19. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients.
Pisa P; Stenke L; Bernell P; Hansson M; Hast R
Anticancer Res; 1990; 10(3):817-20. PubMed ID: 2114819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
